FTSE 100 news / Companies and sectors / Smith & Nephew / 9 October 2026

Smith & Nephew (SN): news on Friday 9 October 2026

+6.8 strongly positive

Coverage centred on the European launch of the CARTIHEAL cartilage implant, which reads as a positive step for its sports medicine business. Analysts' consensus rating of Hold and a scheduled Q3 trading report and call kept the tone measured.

What drove it

CARTIHEAL European launch
analyst Hold ratings
Q3 trading report

The 4 stories

Each headline's own score, strongest first. Links go to the publisher.

+9.2 Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets Yahoo Finance
Product launch of CARTIHEAL across key European markets expands its offering
+7.0 Is Smith & Nephew plc (LSE:SN.) expanding its sports medicine reach with this week's European cartilage implant launch? Kalkine Media
Frames European cartilage implant launch as sports medicine expansion
+5.2 Smith & Nephew launched CARTIHEAL: 18 analysts rate Smith & Nephew stock Hold AD HOC NEWS
Product launch noted, though analysts' consensus rating is only Hold
+0.3 A November 4 analyst call will follow Smith & Nephew (SNN)'s Q3 trading report. Stock Titan
Scheduling notice for Q3 trading report and analyst call; neutral

Smith & Nephew: every day · Pharma and healthcare on 9 October 2026 · FTSE 100 overview for the day